QuickView for SNCB;jsessionid=FAC6F26501ACC752D755F6B36741828C;jsessionid=41CE8D51B1B979E3CE6A82E3763C3390;jsessionid=A25E3868B6EC65AAF4E9E7DAA9AEAC78;jsessionid=DDAF30251AA078A7D7D4C9417FFA182B;jsessionid=27ED7D5F99FFA7A33A4DFB61C9FE3882 (gene)

1. Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease.
2. Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level.
3. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-…
4. New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases.
5. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggrega…

There were no clinical trials for SNCB;jsessionid=FAC6F26501ACC752D755F6B36741828C;jsessionid=41CE8D51B1B979E3CE6A82E3763C3390;jsessionid=A25E3868B6EC65AAF4E9E7DAA9AEAC78;jsessionid=DDAF30251AA078A7D7D4C9417FFA182B;jsessionid=27ED7D5F99FFA7A33A4DFB61C9FE3882